Elin Svensson

Uppsala University is advertising two fully funded PhD positions in pharmacometrics with a strong global health focus at the Department of Pharmacy in Sweden. The positions begin in August 2026 and are linked to two research directions: tropical pharmacology (including malaria and leishmaniasis, with work on mass drug administration strategies and the ERC-funded TRANSPHORM project) and drug-resistant tuberculosis (embedded in the international consortia UNITE4TB and EX-DR TB). The projects use pharmacometric modelling and simulation , pharmacokinetics/pharmacodynamics (PK/PD) , systems pharmacology , and clinical trial data . Successful candidates will develop data-driven models for drug treatment, analyse clinical trial datasets, collaborate with international research groups, and publish and present findings. This is a research-intensive doctoral opportunity for applicants interested in infectious diseases, treatment optimization, and quantitative drug development. Eligibility highlights include an MSc in pharmacy, medicine, engineering, or a related field (or a Master in Pharmaceutical Modelling/Drug Development), with coursework in pharmacokinetics, physiology, pharmacology, modelling, and programming. Strong skills in R and NONMEM are expected, along with advanced English proficiency, teamwork, motivation, and structured research ability. Experience with clinical trials or global health research is considered a merit. The application requires a motivation letter, CV, diplomas and certificates, two recommendation letters, and any thesis or relevant supporting documents. The deadline is 15 May 2026 . Applications must be submitted through Uppsala University’s recruitment system.